thiazoles has been researched along with a 80987 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Denissen, JF; Fino, L; Flentge, CA; Green, BE; Kempf, DJ; Kong, XP; Marsh, KC; McDonald, E; Park, CH; Vasavanonda, S | 1 |
1 other study(ies) available for thiazoles and a 80987
Article | Year |
---|---|
ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans.
Topics: Administration, Oral; Animals; Antiviral Agents; Bile; Bile Ducts; Binding Sites; Biological Availability; Capsules; Female; HIV Protease; HIV Protease Inhibitors; HIV-1; HIV-2; Humans; Injections, Intravenous; Macaca fascicularis; Male; Metabolic Clearance Rate; Models, Molecular; Molecular Structure; Pyridines; Rats; Rats, Sprague-Dawley; Ritonavir; Tablets; Thiazoles; Tissue Distribution; Valine | 1995 |